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ABSTRACT
Pre-exposure prophylaxis (PrEP) has been hailed as a revolutionary
intervention for HIV prevention. PrEP’s controversial status in the
UK has generated significant media coverage. It is important to
understand what role the media plays in framing PrEP policy
issues. We undertook a qualitative analysis of UK newsprint
articles between 2012 and 2016 to examine how PrEP was framed
as a public health intervention up until a controversial policy deci-
sion not to provide PrEP in England. We identified how scientific
evidence was deployed to shape two narratives: ir/responsible citi-
zens focused on imagined PrEP users and their capacity to use
PrEP effectively; and the public health imperative, which described
the need for PrEP. Our analysis demonstrates the particular ways
in which scientific evidence contributed to the certainty of PrEP
as an effective intervention within UK newsprint. Scientific evi-
dence also played a key role in framing PrEP as an intervention
specifically for cis-gendered gay and bisexual men, playing into
wider debates about who is a deserving patient and the appropri-
ate use of public resources. Practitioners in the UK and elsewhere
should be aware of these constructions of the PrEP user to ensure
equitable access to PrEP beyond gay and bisexual men.
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Introduction
In November 2016, the Court of Appeal of England and Wales ruled in favour of a
judicial review brought forward by the National AIDS Trust (NAT), a UK HIV policy
organisation (Court and Tribunals Judiciary 2016). NAT argued that the provision of
pre-exposure prophylaxis (PrEP) – the use of existing HIV treatment in the form of a
(usually) daily pill by HIV-negative individuals to prevent the acquisition of HIV – was
within National Health Service (NHS) England’s remit of provision (NAT 2016). The
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ruling ended a very public court battle challenging NHS England’s controversial March
2016 policy decision that funding PrEP did not fall within its remit. This public battle
garnered significant UK media attention and public debate ensued concerning the
NHS’s role in funding a drug to prevent HIV amongst gay and bisexual men.
Grounded in claims that funding this expensive drug would take away from essential
medicines for more worthy patients (e.g. children, cancer patients), the issue focused
squarely on the high cost of a lifestyle – and not life-saving – drug that was seen to
benefit a minority population (gay and bisexual men). The implicit messages, rein-
forced by homophobic undertones reminiscent of early AIDS reporting (Watney 1987),
were that gay and bisexual men should take responsibility for their own health
through condom use and behaviour modification rather than relying on expensive,
publicly-funded pharmaceuticals (Twocock 2016; Duffy 2016; Mowlabocus 2019).
Although the ultimate legal resolution determined that responsibility for commission-
ing PrEP lay with NHS England – which would come with a new set of controversies –
the debate centred around both who PrEP was for and the need for PrEP itself.
Media reporting on biomedical developments allows us to examine how scientific
evidence itself is deployed, translated and appraised in public spaces. As we have
seen throughout the history of HIV, mass media institutions have played ‘a critical role
in shaping how scientific controversies are interpreted, and adjudicated’ (Epstein 1996,
22). In her work on AIDS as a biomedical and a cultural phenomenon, Paula Treichler
describes how multiple meanings of what we would now term HIV originate, prolifer-
ate and take hold, arguing
we need an epidemiology of signification – a comprehensive mapping and analysis of
these multiple meanings – to form the basis for official definition that will in turn
constitute the policies, regulations, rules and practices that will govern our behaviour for
some time to come… as we have seen, these may rest on ‘facts’, which in turn may rest
on the deeply entrenched cultural narratives (Treichler 1999, 39).
While the scientific evidence for PrEP, including clinical and cost-effectiveness, may have
been clear to experts prior to the NHS England policy decision being taken (Lancet 2016), it
is important to understand how evidence was deployed and shaped by wider cultural narra-
tives, and to consider the specific role of media in framing these UK-wide health policy
issues. In this paper, we examine how UK newsprint media reported PrEP as a public health
intervention prior to the NHS England decision. While the media coverage of PrEP after
March 2016 was steeped in questions around sexuality, responsibility and entitlement, we
ask how PrEP was configured in newsprint media as a public health intervention up until
this point and consider how this may have shaped subsequent public PrEP debates.
Framing public health narratives in newsprint
The media and its engagement with science and related health research play a key
role in shaping public understandings of health (Seale 2002). Indeed, there is long his-
tory of critical analysis focusing on the cultural politics of HIV and AIDS, and the role
of the media in representing and constructing understandings of the HIV epidemic, as
well as shaping policy and public health endeavours (Epstein 1996; Treichler 1999;
Watney 1987). The role of newsprint in particular as emblematic of mass media, and
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how it frames health narratives, has been well established in the social science litera-
ture (McCallum and Holland 2017; Pickersgill et al. 2017; Williams et al. 2008; Hilton
et al. 2010).
In this paper, we examine newsprint media as a discursive site, recognising the role it
plays in shaping understandings of public health and related technologies, but also in
how it engages more directly with wider public health and/or scientific imaginaries
(Davis 2014). Like Pickersgill et al. (2017), we explore how newsprint articles ‘imagine
and articulate’ understandings of science within a UK context. It is important to note
that this relationship – between media and publics – is mediated by the ways in which
media, scientific, health and community stakeholders interact (Briggs and Hallin 2016;
McCallum and Holland 2017). In their book Making Public Health, Briggs and Hallin
(2016) draw on the concept of biomedicalisation (Clarke et al. 2010) to describe how
media and public health actors interact with each other in an increasingly technoscien-
tific era. At a time when media outlets commit fewer resources to producing science- or
health-based stories (Stansistreet 2015), public health and research institutions are
increasingly investing in media specialists to communicate and tailor research findings
for wider publics, including media outlets. Biomediatisation, Briggs and Hallin argue,
results in a shift from reporting to forms of co-producing news stories. Moreover, as
these new mediated communications relationships adapt to ‘the logics and routines of
news media to get their message across, they may gloss over the complexities and con-
tingencies of scientific knowledge’ (McCallum and Holland 2017). For the purposes of
this paper, it is imperative therefore to consider not only who is a part of creating these
public health narratives, but on what evidence they are based and how this evidence is
deployed to produce PrEP itself. In other words, the very nature of what PrEP is as an
intervention is constituted through these configurations of evidence (Rosengarten 2010;
Montgomery 2012).
This paper also considers how the technology user is shaped in or through how the
technology itself is imagined or conveyed (Montgomery 2012; Johnson 2017).
Oudshoorn et al. argue that
‘a semiotic approach to user-technology relations enables us to analyse how, even in
cases where users are not formally involved in the design, technologies may become
adjusted to certain groups of users because of the incorporation of specific images of the
future users’ (Oudshorn, Rommes, and Sinestra 2004).
That is, the end user of a particular technology, including a pharmaceutical inter-
vention, is already imagined and shaped throughout the design and/or implementa-
tion of the technology itself. However, the user and technology interact with and
reconfigure each other to co-constitute technologies. As a result, we need to consider
the ways in which end-users are imagined and re-imagined as technologies are
deployed (Montgomery 2012). We draw on and add to the work of Holt, who explored
how the PrEP user was configured in an earlier PrEP era, through scientific writing
(Holt 2014). Holt focused on how PrEP was configured specifically for gay and bisexual
men through research trial products (e.g. articles, testimonies). While Holt looked pri-
marily at US research, we consider the imagined use of PrEP as told through UK news-
print, paying particular attention to who the PrEP user might be, and if and how they
may be gendered (Johnson 2017; Montgomery 2012).
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In exploring PrEP and its imagined users in UK newsprint, we also engage with the
wider biomedicalisation of HIV (Young, Flowers, and McDaid 2016). The increasing
move to biomedical HIV prevention interventions globally has not been without con-
troversy. Opposition to biomedicalisation of HIV prevention related not only to con-
cerns around costs of pharmaceuticals and fear of technologies, but also the erasure
of social practices which have been instrumental in maintaining prevention (and care)
practices throughout the HIV epidemic (Kippax and Stephenson 2012; Nguyen et al.
2011). Understanding how scientific evidence of efficacy and effectiveness is deployed
within this contested space is critical. Throughout the epidemic, scientific evidence
has been used to shape particular ends and has itself been shaped by social norms
and values (Epstein 1996; Treichler 1999). Paying attention to how and where scientific
narratives of health and prevention emerge in relation to PrEP is also about exploring
how PrEP is framed in relation to wider histories of social and health inequalities.
Methods
We employed a qualitative content analysis approach by undertaking thematic analysis
of the latent content of newspaper articles (Altheide 2012). Latent content here refers
to the underlying meaning of texts, which demands an interpretative coding approach
(Neuendorf and Kumar 2006). We selected 16 mainstream, UK national daily and
Sunday newspapers with high circulations (Press Gazette 2016), and four Scottish
national newspapers, representing a broad range of newsprint readership profiles: The
Daily Mail and The Mail on Sunday; The Daily Telegraph and The Sunday Telegraph; The
Express and The Sunday Express; The Guardian and The Observer; The Independent and
The Independent on Sunday; The Mirror and The Sunday Mirror; The Times and The
Sunday Times; The Sun; and Metro; The Herald & Sunday Herald; The Scotsman &
Scotland on Sunday; The Daily Record and Sunday Mail; and The National. The Sunday
counterpart of The Sun was not archived in the Nexis database used, and Metro does
not have a Sunday counterpart.
This sampling frame includes publications from different newspaper ‘genres’ (tab-
loid, middle-market tabloid and serious), employing a typology used previously (e.g.
Hilton et al. 2010; Patterson, Hilton, and Weishaar 2016) to ensure a sample of publica-
tions representing a demographically diverse range of newsprint reading audiences.
Content included material available through online newsprint coverage.
Our search period started on 1 January 2012, the year that PrEP was approved by
the US Food and Drug Administration (FDA) and covered a period during which PrEP
became recognised globally as a viable HIV prevention tool. We ended our search on
31 March 2016, the point at which NHS England announced their decision not to fund
PrEP. This end point allowed us to focus on how PrEP was configured as an interven-
tion through the media before debates moved more explicitly towards issues of
entitlement. Using the Nexis database, we searched for articles that either contained
‘HIV’ and/or ‘AIDS’ within five words of the term ‘pill’ or contained one or more of the
following terms: ‘Pre-exposure prophylaxis’; ‘Truvada’; ‘anti-aids’; ‘anti-HIV’; ‘HIV drug’
and ‘AIDS drug’. All articles that matched the search string were downloaded and sub-
jected to initial review. This yielded 156 articles. To ensure that only articles
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predominantly reporting on PrEP were included, any articles of which more than 50%
of the text was not relevant to PrEP were excluded. We excluded 109 articles at this
stage resulting in a sample of 47 articles for full review.
All articles were initially read by the first and second authors to generate broad the-
matic categories (Table 1). Articles were systematically read and coded according to
these thematic categories, including recording general interpretative notes about each
article, by authors one, two and three. At this stage, three more articles were
excluded, providing a final sample size of 44 (see Table 2). Only two articles came
from Scottish newspapers, with the remaining 42 from mainstream UK national news-
papers. No separate analysis was undertaken of the Scottish articles due to small num-
bers. To promote consistency, one quarter of the articles were double-coded, and
coders discussed their interpretations of the thematic categories throughout. Once
coding was complete, authors one, two and three employed both a deductive and
inductive approach to analysis by reflecting on article coding, but also drawing on a
grounded theory approach to consider which stakeholders were included in the
articles, what was reported, and how it was presented. Through multiple, iterative dis-
cussions, two broad narratives and a timeline of key PrEP narrative events
were identified.
Findings
Although our search period covered more than 3 years (2012–2016), we found rela-
tively few newsprint articles on PrEP. We also found very little difference in tone or
coverage between different genres of newspaper. Reporting during this period was
largely in response to the publication of UK and international scientific findings, con-
ference presentations and/or policy decisions. In particular, our analysis identified the
release of results from PROUD – a UK based PrEP Randomised Control Trial (RCT) with
gay and other men who have sex with men (men who have sex with men) in England
– as a central scientific event in patterns of reporting in UK newsprint. It was possible
to identify two distinct time periods in PrEP reporting: Priming for PROUD, 15 articles
from July 2012 to October 2014 and; the Post-PROUD period from February 2015 to
the end of March 2016, 29 articles, two-thirds of the sample. The beginning of the
Post-PROUD period, which followed three months in which no reporting on PrEP was
identified, began with reporting on the presentation of UK PrEP trial PROUD findings
at the International Conference on Retroviruses and Opportunistic Infections (CROI), a
key HIV scientific conference. From February 2015 onwards, reporting substantially
changed in focus and tone.
Table 1. Broad thematic coding categories.
1. What is the main focus of the article?
2. What is the main tone of the headline?
3. What is the main tone of the article?
4. Who is making comments about PrEP?
5. How is PrEP being framed?
6. Interpretative comments on the form and structure of the article
7. How does the article draw on scientific evidence?
8. What are the reported criticisms of PrEP?
9. What are the reported benefits of PrEP?
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Table 2. Final sample of newsprint articles January 2012–March 2016.
Date Newspaper Headline
Priming for PROUD
9 May 12 Daily Mail First drug to prevent as well as treat HIV a step closer to approval
17 July 12 Guardian US FDA approves first drug shown to reduce risk of HIV infection
17 July 12 Guardian US approves pill that guards against HIV: Truvada to be available
to people at extreme risk AIDS support group labels move
‘completely reckless’
17 July 12 Daily Mail The first drug which can PREVENT HIV: pills reduce risk by up to
75% in at risk heterosexual couples
13 June 13 Daily Mail New AIDS prevention pill could cut infection rates in IV drug users
by 50%
10 February 14 The Times Trial of pill to prevent HIV could lead to a risk in promiscuity
25 April 14 Daily Mail More mixed-status couples conceiving children without protection
as new treatments minimise the risk of infection
17 May 14 Daily Mail Pressure grows on NHS to make new HIV wonder drug available
for those at risk
17 May 14 The Independent NHS urged to prescribe daily HIV pill to gay men
8 September 14 Daily Mirror Revolution that could halt epidemic of HIV
30 September 14 Guardian HIV protection in a pill for those at risk
17 October 14 The Times Coming soon: the daily pill that can protect against HIV
17 October 14 Daily Mail ‘Wonder drug’ which can reduce HIV risk by 92% could be offered
on the NHS
18 October 14 Guardian Analysis: an HIV prevention pill is at hand, but will it be
left untaken?
30 October 14 The Independent Revolutionary new anti-HIV pill shown to work when taken
‘on demand’
Post-PROUD
24 February 15 The Independent HIV pill: the logic of paying £500 a month so gay men don’t have
to wear condoms
24 February 15 Telegraph Scientists hail daily pill that cuts HIV risk by 87%
25 February 15 The Sun DOCS’ PLEA FOR HIV PILL ON NHS
25 February 15 The Independent Scientists hail daily pill that protects against HIV infection
25 February 15 The Independent The logic of paying £500 a month so gay men don’t have to
wear condoms
25 February 15 The Independent HIV pill: Scientists hail discovery of ‘game-changer’ that cuts the
risk of infection among gay men by 86%
25 February 15 Guardian Daily pill Truvada cuts spread of HIV by 86% study shows
25 February 15 Daily Telegraph Before-and-after pill cuts HIV risk
25 February 15 The Times Daily pill reduces HIV risk by 90%
25 February 15 The Scotsman HIV game-changer as drug protects healthy gay men
26 February 15 Daily Mail HEALTHY GAY MEN SHOULD BE GIVEN £440-A-YEAR HIV PILLS ON
THE NHS’
26 June 15 The Independent Pride in London: NHS to come under pressure to provide ‘miracle’
HIV prevention pill
27 June 15 The Independent Pride hears calls for NHS to introduce HIV pill
10 October 15 The Independent Daily pill that lowers HIV risk ‘could save NHS millions’
10 October 15 The Independent NHS ‘cannot afford to ignore game-changing HIV drug’, experts say
11 October 15 The Independent Cheap at the price; Editorial The NHS should fund prescription of a
new AIDS treatment
11 October 15 The Independent AIDS vanquished: a costly new pill promises to prevent
HIV infection
24 October 15 Daily Mail Could drugs to prevent HIV actually INCREASE the risk of infection
by encouraging people not to use condoms?
16 November 16 Daily Mail Once-a-day pill ‘DOES prevent HIV in the real world’: PrEP drugs
‘are effective in protecting health gay men from infection’
2 December 15 The Herald HIV charity in call for NHS to prescribe drug
11 December 15 Guardian The choice to take the HIV prevention pill has nothing to do
with sluttiness
14 January 16 The Times Fears HIV pill could encourage risk behaviour
14 January 16 Telegraph Daily HIV pill for men ‘would prevent 10 000 new cases in UK
by 2020’
(continued)
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We also identified two broad narratives. The first narrative, ir/responsible citizens,
focused on PrEP users and their capacity and responsibility to use PrEP correctly,
which framed the un/certainty of PrEP as an effective intervention. The second narra-
tive, the public health imperative, described if and why PrEP might be needed as a
public health intervention. There was a marked difference in both themes in the two
time periods (see Table 3).
Ir/responsible citizens: priming for PROUD
During this period, imagined PrEP users and their sexual practices were presented as a
source of unknown or increased risk were PrEP to be made available. Descriptions
focusing on potential reduction in condom use and its assumed related increases in
harms (e.g. increased risk of HIV and STIs) characterised PrEP users as irresponsible.
While not always the dominant message, this narrative was consistently present.
Regular, ongoing constructions of irresponsible PrEP users were juxtaposed with, and
in some cases part of, expert opinion and reporting on scientific findings. Familiar
stereotypical language (Watney 1987) used to paint PrEP users as irresponsible citizens
included ‘unsafe sex’ when describing condomless sex, calling PrEP a ‘party drug’, and
describing ‘increased risk taking’, ‘promiscuity’ and/or a ‘reduction of condoms’.
Table 2. Continued.
Date Newspaper Headline
14 January 16 Daily Mail Daily pill to prevent HIV may be offered to thousands of men on
the NHS after trials showed it could cut risks by 60%
25 February 16 Daily Mail Gay man taking daily HIV prevention pill contracts resistant strain
of the virus – in first recorded case of PrEP failing
21 March 16 Daily Mail Could a monthly injection prevent HIV? Single shot of PrEP drugs is
‘as effective as taking pills twice a day’
25 March 16 Guardian NHS England stalls plan for HIV prevention drugs
22 March 16 The Times Pill to stop HIV will not get funding
22 March 16 Daily Mail Charities slam NHS England and ‘U-turn’ over plans to roll out ‘HIV
wonder drug’
Table 3. Overview of findings according to theme and time period.
Ir/responsible citizens Public health imperative
Priming for PROUD
July 2012–January 2015
 PrEP users as potentially
irresponsible actors
 Risk of STIs/reduced
condom use
 Mixed or unsupportive
community responses
 PrEP effectiveness in ‘real world’
is uncertain
 New infections globally with
increased focus on vulnerable
women and/or
general population
 PrEP as expensive/costly
Post-PROUD
February 2015–March 2016
 PrEP users as responsible
 An absence of ‘risky’
sexual practices
 Limited or stable STIs
 PrEP will work/certainty of
intervention
 PrEP is a ‘game-changing’
intervention
 Gay & bisexual men in UK at
most risk of HIV and in real
need of new prevention tools
 Limited or no discussion of PrEP
for other groups
 PrEP is a cost-effective
intervention
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Voices from community opposition to PrEP were used to air many of these concerns.
Quotes evidencing opposition to PrEP came mainly from the AIDS Healthcare Foundation, a
US organisation known for strong opposition to PrEP, with its founder Michael Weinstein by
far the most quoted voice. Weinstein and other community voices argued that the provision
of PrEP would lead to a ‘false sense of security’ (Daily Mail, 17 July 2012) and threaten con-
dom use, the most reliable prevention measure against HIV. The irresponsible citizen narra-
tive highlighted specific problems which would cause the ‘failure of PrEP’. In many articles,
PrEP failure was characterised by poor adherence, in which people were imagined not to
take PrEP regularly because of forgetfulness or side effects. However, the dominant failure
comprised forms of ‘risk compensation’, whereby PrEP would facilitate an increase in STIs
(and possibly HIV) because of reduced condom use, and an assumed change in sexual prac-
tice to increased sexual partners and ‘risky behaviours’.
In some articles, key UK scientific or community HIV experts refuted or tempered the
ir/responsible characterisation of the imagined PrEP user. While Professor Sheena
McCormack, head of the UK PROUD trial, expressed concern about encouraging risky sex-
ual behaviour, she was also reported as providing examples or situations in which con-
dom use might not be possible, and explaining how PrEP could be about ‘helping
people to be responsible’ in these cases (The Times, 17 October 2014). Similarly, Justin
Harbottle from a well-known HIV charity, Terrence Higgins Trust (THT), described fears
around PrEP as ‘misplaced’, and compared PrEP to the contraceptive pill, highlighting
the need for choices of prevention method (Independent, 17 May 2014). In spite of these
tempered comments, reporting in most articles cast doubt on the capacity or willingness
of PrEP users to act responsibly and use PrEP correctly, thus potentially undermining
PrEP’s effectiveness to prevent HIV.
Ir/responsible citizens: post-PROUD
With the presentation of PROUD results in February 2015, there was a noticeable shift
in the representation of imagined PrEP users. In contrast to the sustained focus on the
potential failure of PrEP users in the earlier period, specific mention of PrEP users and
their capacity to use PrEP was largely absent. Instead, comment was offered on the
use of PrEP and ongoing use of condoms, suggesting the capacity of PrEP users to act
‘responsibly’.
A study of British men showed that they were willing to take the pill, which did not
appear to encourage unsafe sex… . It is allowing individuals to negotiate what sort of sex
they want. It provides them with protection. (The Times, 25 February 2015)
Although articles continued to refer to condomless sex as ‘unsafe’, there was a
marked absence of reporting on the potential for ‘irresponsible’ sexual practice. One
article, reporting the PROUD study findings published in The Lancet, addressed these
previous concerns directly.
A key concern has been that Truvada would become a ‘party drug’, used instead of
condoms to prevent infection, thereby having the unwanted side-effect of increasing the
risk of passing on other sexually transmitted infections. But this, it turns out, has not been
the case – there was no significant increase in other STDs recorded during the Lancet
trial. (Independent, 11 September 2015)
8 I. YOUNG ET AL.
Other articles, while not refuting a previous stance outright, used more neutral
language in their reporting.
Since PrEP does not work all the time, nor does it prevent sexually transmitted infections
like syphilis and gonorrhoea, health authorities say people should continue to use
condoms regularly. (Telegraph, 24 February 2015)
Instead of focusing on specific users, articles reminded readers that PrEP did not
prevent STIs, rather than undermine PrEP as an intervention itself.
A small minority of articles raised the issue of the potential of decreased condom
use and increased STIs if PrEP were made available, but this was often tempered by,
or refuted with, evidence from the PROUD study:
Men taking part in the study reported they did not change their condom use because of
PrEP – evidence that was borne out by the fact that infection rates of other STIs were
similar in both groups. (Independent, 25 February 2015)
Of the 29 articles from this period, there were two notable exceptions to this
portrayal of imagined PrEP users. Similar to the irresponsible citizen theme in the ear-
lier period, two articles described concerns around promiscuity or ‘riskier sex without
condoms’ (Daily Mail, 26 February 2015). Both reported and asked directly if PrEP
would ‘encourage risky sex’ (The Times, 14 January 2016), with one article referencing
US criticisms. However, both articles also reported evidence from PROUD showing no
increase in STIs between the PrEP and deferred arms of the study. The tone of these
articles was more negative, as the articles’ structure diminished this evidence, focusing
instead on potential risks of PrEP. The tone and emphasis of these articles, however,
were not in keeping with most articles from this time period.
Voices from community activists and PrEP users were largely absent during
this period. This meant that although Weinstein’s opposition was no longer present,
neither were there community voices discussing the potential for PrEP. This scientific
discussion contrasted with the narratives around PrEP users present in the earlier
period. The absence of comment on, or tempered representation of, potential risks
from PrEP – thanks in large part to the PROUD findings – resulted in a diminishing
of the irresponsible citizens narrative and a shift towards a potentially effective
intervention itself.
Public health imperative: priming for PROUD
Articles in the early period consistently provided general estimates of HIV diagnoses in
UK, USA or globally. Descriptions included total numbers of HIV diagnoses and
expected yearly diagnoses. Some, especially of the UK epidemic, also referenced the
number of people estimated to be undiagnosed.: ‘… 96,000 people in the UK are
currently living with HIV. Of these people, 22,600 are thought to be unaware of their
infection’ (Daily Mail, 13 June 2013). Some articles went on to identify groups most at
risk of, or affected by, HIV. This often included a list of groups including gay and
bisexual men, people in relationships with someone living with HIV and people who
inject drugs.
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Of the 6280 new cases of HIV in 2011, around 48% were infected through heterosexual
sex, and 48% through sex between men… . The CDC now estimates as many as 275,000
uninfected gay men and 140,000 heterosexual couples, in which one partner is HIV-
infected, could benefit from PrEP. (Daily Mail, 17 May 2014)
With the announcement in October 2014 that the PROUD trial would be offering
PrEP to all participants, including those on the deferred arm, the presentation of epi-
demiological evidence shifted noticeably. Articles began to include information about
HIV rates which more obviously focused on the specific benefit of PrEP for gay and
bisexual men.
Nearly 100,000 people are living with HIV in the UK. Sex without a condom is the most
common means of infection. Nearly half of all new infections are among men who have
sex with men. (Independent, 30 October 2014)
Some articles addressed the cost of PrEP as they explored the need for the inter-
vention. Available at the time only as patented drugs, PrEP was reported as very
costly. One article outlined that ‘the drug is likely to raise questions over its high price’
(The Times, 10 February 2014), indicating that it may not be a cost-effective interven-
tion. Other articles towards the end of the period outlined similar concerns but indi-
cated that there may be ways around the normally prohibitive pricing.
If the final results are good, public-health experts hope the drug could be made available
on the NHS to those at high risk, although negotiations would have to take place with
manufacturer Gilead to find a price the health service can afford. The drug can cost the
equivalent of £7500 a year in the US. (The Guardian, 18 October 2014)
High cost combined with a more general framing of HIV as a public health issue,
rather than for a specific group, presented uncertainty in PrEP as a viable intervention,
ready for implementation.
Public health imperative: post-PROUD
By February 2015, and the announcement of PROUD findings at CROI, the presentation
of any HIV context in the articles now focused almost entirely on gay and bisexual
men in the UK. Articles included specific information on existing HIV rates amongst
this group, and the potential numbers of gay men who could benefit from PrEP.
Men who have sex with other men are most at risk of HIV, accounting for nearly half of
the 6000 new cases each year. One in 26 gay men in the UK estimated to have the
disease, rising sharply to one in eight in London. (Daily Mail, 14 January 2016)
Noticeably absent from most articles were references to other groups for whom
PrEP might be helpful. This was in stark contrast to articles from the earlier time
period. There was no mention of trans individuals and communities in spite of their
being disproportionately affected by HIV (Baral et al. 2013). We note, therefore, that
references to gay and bisexual men were largely, if not exclusively, made with cis-gen-
dered gay men in mind.
Exceptionally, a very small number of articles from this time period did not present
PrEP as a public health need in the same way. Two articles from the Times continued
to provide a broader HIV context. One, which reported the modelled effects of PrEP
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on HIV infection rates amongst gay men in the UK, raised the need for attention to
‘other at-risk groups’:
[… ] if all gay men were offered it, infection rates would fall by 59%, preventing 10,000
cases of HIV by 2020. Even if it were limited to the quarter of gay men who have more
than one new sexual partner a year, 7400 cases would be prevented… . What about
women and others at risk of HIV? Women with an HIV-positive partner are likely be
included. Gay men will be prioritised because they are high-risk, easy to identify and
those coming to clinics are keen to protect themselves. Evidence of effectiveness is also
stronger. Other at-risk groups, such as some African communities and drug users, will be
considered later. (The Times, 14 January 2016)
A third article, which described new modes of PrEP delivery, such as vaginal rings
and injectable PrEP, described how ‘vaginal transmission accounts for the majority of
new HIV infections across the world’ (Daily Mail, 21 March 2016).
The public health imperative theme during this period also drew on cost to frame
PrEP certainty and need. Whereas earlier reporting focused on the expense of PrEP,
reporting here drew on the cost-effectiveness of PrEP as an intervention to prevent
HIV. Articles acknowledged ongoing high costs of PrEP, but described how such an
effective intervention, if used by the most appropriate PrEP users, would result in lon-
ger term savings to the NHS.
[… ] it will have to consider whether the pills, which will cost £423 per month for each
patient, will be cost-effective, and what the criteria should be for accessing them… If we
can stop people getting HIV by giving them PrEP, we have an ethical duty to do so.
Furthermore, over the course of their lifetime the treatment of those 19 men will cost the
NHS nearly £7m. So the financial argument is clear, as is the ethical one. PrEP needs to
be available on the NHS as soon as possible for all those who need it. (Independent, 25
February 2015)
The imperative for PrEP was also captured in specific language used by public
health experts. Articles frequently and repeatedly drew on THT Medical Director Dr.
Michael Brady’s description of PrEP as a ‘game-changer’, encapsulating the need for
PrEP as a significant tool with which to combat the current, and urgent, HIV epidemic
amongst gay and bisexual men in the UK. With such an effective intervention that
would save the NHS money in the longer term, the public health imperative to imple-
ment this ‘game-changing’ intervention was clear.
Discussion
In an era of increasing pharmaceutical prevention-based policies and the need to
understand what shapes policy implementation, our analysis illustrates how specific
forms of scientific evidence about PrEP were deployed within UK newsprint, playing
an important role in the configuration of imagined PrEP users. Coverage during this
period mobilised scientific evidence, first to characterise PrEP as an uncertain interven-
tion in the context of an ongoing, global epidemic and, ultimately, to frame PrEP as
much needed, ‘game-changing’ public health intervention specifically for gay and
bisexual men. Reporting initially queried the capacity of individuals to use PrEP appro-
priately, drawing on well-rehearsed stereotypes to suggest that irresponsible sexual
practice would threaten the effectiveness of the intervention. However, PROUD trial
CULTURE, HEALTH & SEXUALITY 11
results were used to show that PrEP users had the capacity to act as responsible citi-
zens (Young et al. 2019). This shift in reporting and diminishing doubt about PrEP use
added weight to the certainty of PrEP as a feasible and effective intervention within
these UK media narratives.
The use of community and scientific voices was key in the framing of evidence (Briggs
and Hallin 2016). The inclusion of community voices and some opposition in the early
period framed PrEP as an uncertain intervention. This opposition – along with most com-
munity voices – disappeared from newsprint sources with the success of PROUD, as the
role of scientists, clinicians and policy makers took centre stage. Drawing on scientific evi-
dence, including randomised controlled trials findings, epidemiological need and cost-
effectiveness modelling, the articles wove a story of need for PrEP as new HIV prevention,
primarily for gay and bisexual men in the UK. In spite of ongoing global epidemiological
need, UK newsprint framing of PrEP narrowed in on specific communities, excluding the
possibility of wider user and went some way to close down the possibility of the interven-
tion as something of use to the general population. Unlike new cancer treatments or
other interventions that would impact the wider population, PROUD results were mobi-
lised here to confirm the effectiveness of the intervention for gay men (Holt 2014). Our
analysis focused exclusively on newsprint media, without reference to social media cover-
age of PrEP; however, the shift between community and clinician to clinician/scientist
within this reporting reflects a closing down of who is creating the story of PrEP and how
this might reflect and/or influence – or certainly frame – the imagined PrEP user in wider
cultural narratives that affect policy (Treichler 1999).
Our analysis adds to a relatively small body of PrEP media analyses during a similar
period (Card et al. 2019; Mowlabocus 2019; Jaspal and Nerlich 2017) by showing how
scientific evidence was deployed to shape both the reliability of the intervention and
to construct PrEP users. Jaspal and Nerlich (2017) investigate PrEP newsprint coverage
during an overlapping period (2008–2015), illustrating the use of either highly positive
or highly negative representations of PrEP through narratives of hope or risk. Looking
explicitly at how PrEP is anchored and how this might affect uptake of PrEP, they
argue that this polarisation could close down nuanced and realistic understandings of
PrEP for potential users. Our analysis, incorporating coverage of PrEP one year after
the PROUD findings, found that narratives of hope and risk were only part of the story;
we found that intervention effectiveness (and certainty), epidemiological need and cul-
tural narratives of responsible sexual practice played an important role in how PrEP
users were configured. Mowlabocus’ (2019) explicitly considers how homonormativity
is deployed during a period which incorporates coverage of the post-NHS England
policy decision and highlights the persistence of well-rehearsed stereotypes of gay
men. Findings show how these stereotypes were largely absent during the post-
PROUD period, suggesting that the media deployment of PrEP evidence tempered –
for a time – these familiar, homophobic tropes. While many of these articles – either
explicitly or implicitly – explore PrEP in relation to LGBT identities and sexual practices,
we argue that attention needs to be paid to the deployment of scientific evidence
and its specific role in shaping who PrEP was for.
By mapping articles against key scientific events, we illustrate how reporting of par-
ticular scientific findings plays a key role shaping narratives around new public health
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interventions. We argue that this is an example of the processes of biomediatisation
at work (Briggs and Hallin 2016). More than simply influencing users, the elements we
have identified – the deployment of scientific narratives around end users, interven-
tion effectiveness and epidemiological need – are constitutive of PrEP as an interven-
tion for a ‘minority’ of the population, thereby shaping the boundaries of debate and
the terms on which value, need and ultimately policy debates might be based.
Noticeably absent within UK newsprint reporting were key global PrEP scientific
events; the publication of World Health Organisation prevention guidelines,
which recommended PrEP for men who have sex with men (WHO 2014) and the failed
clinical results from other major PrEP trials with women (Rossi 2013) would also play
a role in configuring potential PrEP users internationally. We suggest that this
absence in UK newsprint is indicative of key events influencing UK policy and reflects
the UK domestic PrEP agenda, rather than engaging or ignoring the wider global
scientific context.
Ultimately, the PrEP user, configured as a cis-gendered gay and bisexual man, was
consolidated during this time period. While gender (and sexuality) in pre-PROUD UK
newsprint was non-specific and referenced a general population in the global
epidemic, PrEP emerged as a specific intervention for gay and bisexual men.
Gendered configurations of PrEP users have implications for how communities, health
practitioners and policy makers engage with PrEP in real world settings. Indeed, this
articulation of PrEP users could certainly be implicated in NHS England’s PrEP decision,
which appeared to draw on underlying (or overt) notions of who is a deserving (and
responsible) patient (Keogh 2008). This configuration of PrEP users, grounded in
particular gender identities and sexual practices, would become apparent in
subsequent reporting (Twocock 2016; Mowlabocus 2019). While the genuine PrEP
need for gay and bisexual men should be highlighted, the possibility of other users
was lost, or significantly diminished; this reinforces existing inequalities and reflects
patterns observed through the HIV epidemic. However, we can currently see attempts
to address and expand this particular gendered framing of PrEP users by activists
in the UK (PrEPster 2018; Sophia Forum 2018).
Strengths and limitations
This research has focused exclusively on newsprint media (including in print and
online editions) and excluded social media coverage of PrEP which may have identi-
fied a more community-informed focus. We also limited our analysis to March 2016,
thereby excluding responses to NHS England’s policy decision and subsequent high
court battles. Whereas post-March 2016 reporting focused significantly on the rights
and wrongs of the NHS decision, we were keen to explore how evidence was
deployed and users configured in the lead up to this controversial decision. Our ana-
lysis is also specific to UK newsprint and does not chart differential patterning of wider
global PrEP implementation. Nevertheless, a strength of our analysis is the focus on
the ways that scientific reporting can open up or close down spaces in which poten-
tial PrEP users are imagined, and has implications for whether, and how, PrEP users
may engage with and take up the interventions elsewhere.
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Conclusion
Scientific evidence, as reported in mainstream newsprint media, can play an important
role in shaping the public health – or technological – imaginaries (Davis 2014) in relation
to trust of an intervention and configuring potential end users. While scientific evidence
can increase confidence in PrEP as well as other new public health technologies, these
configurations can close down possibilities for other users, reinforce ideas of who is a
deserving patient and play into wider concerns about the use of public resources for
improving health and wellbeing. Following Triechler, we argue that there is a need to
attend to language as a site in which the meanings of PrEP are constructed and deter-
mined. The PrEP story told in UK newsprint in the lead up to NHS England’s decision is
only one of the many meanings of PrEP, and the role that it played in this decision is
both unclear and beyond the scope of this paper. Nevertheless, charting the way in
which scientific evidence and community voices in relation to public health need
emerged during this period call attention to how media can craft and shape key issues in
relation to public health, deserving publics and policy decisions. Our findings have impli-
cations for clinical and community practice in HIV prevention. Practitioners who work
with women, trans communities and others who may benefit from PrEP should not only
be aware of these media framings but will need to play an active role in responding to –
and rebalancing – them to help identify and support those who may benefit from PrEP.
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